XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses:        
Research and development $ 798,247 $ 2,105,815 $ 5,332,698 $ 6,994,866
Intangible asset impairment charge 0 8,639,000 0 8,639,000
General and administrative 2,124,785 1,930,082 6,390,663 5,510,365
Depreciation 0 19,100 0 67,302
Loss from operations 2,923,032 12,693,997 11,723,361 21,211,533
Interest income (124,710) (50,710) (207,897) (146,354)
Loss from operations before income tax benefit (2,798,322) (12,643,287) (11,515,464) (21,065,179)
Income tax benefit 0 (443,893) 0 (443,893)
Net loss $ (2,798,322) $ (12,199,394) $ (11,515,464) $ (20,621,286)
Per share information:        
Net loss per share of common stock, basic and diluted (in dollars per share) $ (1.37) $ (5.99) $ (5.65) $ (10.76)
Weighted average shares outstanding, basic and diluted (in shares) 2,039,089 2,037,978 2,038,716 1,916,107
Comprehensive loss:        
Net loss $ (2,798,322) $ (12,199,394) $ (11,515,464) $ (20,621,286)
Unrealized loss on marketable securities (372) 0 (86,955) 0
Comprehensive loss: $ (2,798,694) $ (12,199,394) $ (11,602,419) $ (20,621,286)